FKBP14 Antikörper (AA 20-211)
Kurzübersicht für FKBP14 Antikörper (AA 20-211) (ABIN5775942)
Target
Alle FKBP14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 20-211
-
Verwendungszweck
- Human FKBP22/FKBP14 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human FKBP14 (20-211aa) purified from E. coli
-
Isotyp
- IgG1 kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- FKBP14 (FK506 Binding Protein 14, 22 KDa (FKBP14))
-
Andere Bezeichnung
- FKBP22/FKBP14
-
Hintergrund
- FKBP14, also known as 22 kDa FK506-binding protein, is an enzyme that accelerates the folding of proteins during protein synthesis. This protein contains two EF-hand domains and one PPIase FKBP-type domain. Truncation of the amino-terminus of FKBP14 greatly reduces peptidyl prolyl cis-trans isomerase activity, therefore suggesting that the PPIase FKBP-type domain must be located at the N-terminus.
-
NCBI Accession
- NP_060416
-
Pathways
- ER-Nucleus Signaling
Target
-